Should you buy Astera Labs stock now?
Yes, the technical signal for Astera Labs is currently Strong Buy. Astera Labs trades at $389.80 as of Oct 7, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 18.662 with rising momentum (signal: 13.711); RSI is at 67.7 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $389.95 points to 0.0% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Astera Labs stock?
The average analyst price target for Astera Labs is $389.95. The current price is $389.80, which gives an upside of 0.0%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $350.96 and $428.95.
Is Astera Labs a dividend stock?
No, Astera Labs does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Astera Labs stock?
Astera Labs is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 98.8%, which classifies the stock as Extremely speculative.
Is Astera Labs overvalued?
Astera Labs is considered fairly valued – the price is close to the analyst price target. Astera Labs has the following valuation ratios: a P/E ratio of 172.6 (highly valued), a P/S ratio of 50.6, a P/B ratio of 36.2. The stock trades close to the analyst price target and is considered fairly valued.
Is Astera Labs overbought?
No, Astera Labs is not overbought. RSI is at 67.7 (neutral zone). The technical indicators show: RSI is at 67.7 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 18.7% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Astera Labs earnings report?
Astera Labs reports its next earnings on November 3, 2026. The stock currently trades at $389.80. With a P/E ratio of 172.6, the market will be watching closely whether earnings meet expectations. The RSI is at 67.7, so the report can reinforce the current technical trend.
Is Astera Labs shorted?
Yes, Astera Labs is shorted with 6.6% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Astera Labs stock?
No, insiders are not buying Astera Labs shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 6 sales. On a net basis, 1,542,070 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 107,860,468 $ sold. Active sellers include Dyckerhoff Stefan A, ALBA MANUEL, Mohan Jitendra and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Astera Labs a good stock?
Based on our total score, Astera Labs is rated as a mediocre stock with a total score of 53 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 4/100, Quality: 69/100, Momentum: 88/100. In addition: technical signal: Strong Buy. Whether Astera Labs is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Astera Labs stock?
The outlook for Astera Labs based on current data: the average analyst price target is $389.95 (+0.0%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on Nov 3, 2026, which can move the price; the P/E ratio is 172.6 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Astera Labs stock rising?
Astera Labs is rising right now. The technical indicators show: the price is 18.7% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 6.6% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Astera Labs go?
The average analyst price target for Astera Labs is $389.95, which corresponds to a potential gain of 0.0% from the current price of $389.80. The stock has traded between $97.89 and $499.48 over the last 52 weeks. The price is 22.0% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Astera Labs fall?
The stock has traded as low as $97.89 over the last 52 weeks — that is 74.9% below the current price of $389.80. The biggest decline (drawdown) in the same period was 80.4% from high to low. Within a year, the price typically swings about ±98.8% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Astera Labs do?
Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying so... The company belongs to the Technology sector, more specifically the Semiconductors industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Astera Labs as an investment.
Did Astera Labs raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Astera Labs. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Astera Labs making money or losing money?
Yes, Astera Labs is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 30.7% — which is excellent. The operating margin (profit before interest and taxes) is 22.7%. At a P/E ratio of 172.6, you currently pay 172.6 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Astera Labs go bankrupt?
The bankruptcy risk of Astera Labs is rated as low. Altman Z2 (a model for assessing financial distress) is 15.39 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 9% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Astera Labs have a lot of debt?
No, Astera Labs has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 9%. For the technology sector, anything below 60% counts as low debt. Tech companies are usually asset-light and need little borrowed capital — anything below 60% counts as low in this sector. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
